Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$17,500.00

Effect of intestinal fecal metabolites on Campylobacter jejuni gene expression and pathogenesis

EF 2013-14

Résumé
Campylobacter jejuni (C. jejuni) is one of the most common causes of bacteria associated food poisoning in the world. In Canada, C. jejuni causes more cases of food poisoning than Salmonella and Escherichia coli combined. C. jejuni lives in the digestive tracts of poultry and other food-producing animals without causing disease, and humans are generally infected due to consumption of contaminated chicken and meat products. The resulting disease can be severely debilitating, ranging from mild to bloody diarrhea, abdominal pain, fever, nausea, and vomiting. Rare complications such as bloodstream infection and nervous system disorder (i.e. Guillain-Barre syndrome) have also been documented. The reason why C. jejuni harmlessly colonizes chickens at high concentrations, but cause such severe disease response in humans, is currently unknown. Since C. jejuni colonizes the intestines in both humans and chickens, there are likely different signals found in these environments that make C. jejuni cause disease in humans but not chickens. We hypothesize that these signals are in the form of small molecules (metabolites) that are produced by the host or the intestinal microbial community, or may even be products of digestion. These intestinal metabolites may interact with C. jejuni and lead to higher or lower expression of genes that are specifically associated with disease. To study the influence of these intestinal metabolites, we will expose C. jejuni to metabolites extracted from both chicken and human feces, and then evaluate how C. jejuni responds and which genes are differently expressed. Initial C. jejuni response to chicken vs. human intestinal metabolites will be characterized based on differences in cell shape, growth rate, swimming motility, biofilm formation (ability to adhere to and grow on a surface), and ability to invade intestinal epithelial cells. Gene expression levels will be measured and compared using a method called RNA sequencing (RNAseq). RNAseq is a powerful tool used to identify and quantify which genes are actively being copied from the DNA in individual conditions. In depth analysis will be performed by making gene deletions or over-expressing individual genes that show the greatest difference in expression when exposed to chicken and human intestinal metabolites. This proposed experimental plan will be able to identify specific human pathogenesis related genes and determine their effects on C. jejuni growth and ability to invade intestinal cells. This study will bring us one step closer to understanding why C. jejuni causes disease in humans but not in chickens by identifying genes that are specifically turned “on” or “off” when exposed to metabolites found in the different intestinal environments. Knowing which genes are differentially expressed will add to our understanding of this pathogen and may lead to novel targets for antimicrobial therapy.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
312026
Name
Liu Martha M
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Effect of intestinal fecal metabolites on Campylobacter jejuni gene expression and pathogenesis
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Campylobacter Jejuni; Chicken; Faecal Extract; Gene Expression; Human; Intestinal Metabolites; Pathogenesis; Rna Sequencing; Transcriptome; Virulence
Abstract
Campylobacter jejuni (C. jejuni) is one of the most common causes of bacteria associated food poisoning in the world. In Canada, C. jejuni causes more cases of food poisoning than Salmonella and Escherichia coli combined. C. jejuni lives in the digestive tracts of poultry and other food-producing animals without causing disease, and humans are generally infected due to consumption of contaminated chicken and meat products. The resulting disease can be severely debilitating, ranging from mild to bloody diarrhea, abdominal pain, fever, nausea, and vomiting. Rare complications such as bloodstream infection and nervous system disorder (i.e. Guillain-Barre syndrome) have also been documented. The reason why C. jejuni harmlessly colonizes chickens at high concentrations, but cause such severe disease response in humans, is currently unknown. Since C. jejuni colonizes the intestines in both humans and chickens, there are likely different signals found in these environments that make C. jejuni cause disease in humans but not chickens. We hypothesize that these signals are in the form of small molecules (metabolites) that are produced by the host or the intestinal microbial community, or may even be products of digestion. These intestinal metabolites may interact with C. jejuni and lead to higher or lower expression of genes that are specifically associated with disease. To study the influence of these intestinal metabolites, we will expose C. jejuni to metabolites extracted from both chicken and human feces, and then evaluate how C. jejuni responds and which genes are differently expressed. Initial C. jejuni response to chicken vs. human intestinal metabolites will be characterized based on differences in cell shape, growth rate, swimming motility, biofilm formation (ability to adhere to and grow on a surface), and ability to invade intestinal epithelial cells. Gene expression levels will be measured and compared using a method called RNA sequencing (RNAseq). RNAseq is a powerful tool used to identify and quantify which genes are actively being copied from the DNA in individual conditions. In depth analysis will be performed by making gene deletions or over-expressing individual genes that show the greatest difference in expression when exposed to chicken and human intestinal metabolites. This proposed experimental plan will be able to identify specific human pathogenesis related genes and determine their effects on C. jejuni growth and ability to invade intestinal cells. This study will bring us one step closer to understanding why C. jejuni causes disease in humans but not in chickens by identifying genes that are specifically turned “on” or “off” when exposed to metabolites found in the different intestinal environments. Knowing which genes are differentially expressed will add to our understanding of this pathogen and may lead to novel targets for antimicrobial therapy.
Competitiondate
201312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Liu, Martha M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~